お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は胃食道逆流症（GERD）治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは胃食道逆流症（GERD）治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の胃食道逆流症（GERD）治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは胃食道逆流症（GERD）治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に胃食道逆流症（GERD）治療市場を分類しています。本研究に含まれる主な企業は：AstraZeneca、Eisai、GSK、Takeda、Johnson & Johnson

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Antacids
    Pro-kinetic agents
    H2 Receptor Blockers
    Proton Pump Inhibitors (PPIs)

用途別の市場セグメント：
    Heartburn
    Acid reflux disorders

本レポートの詳細内容
世界の胃食道逆流症（GERD）治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、胃食道逆流症（GERD）治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の胃食道逆流症（GERD）治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の胃食道逆流症（GERD）治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、胃食道逆流症（GERD）治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

胃食道逆流症（GERD）治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：胃食道逆流症（GERD）治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：胃食道逆流症（GERD）治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章胃食道逆流症（GERD）治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：胃食道逆流症（GERD）治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：胃食道逆流症（GERD）治療の主要企業の概要を提供し、製品の説明と仕様、胃食道逆流症（GERD）治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market
The global Gastroesophageal Reflux Disease (GERD) Therapeutics market is projected to grow from US$ 4716.4 million in 2024 to US$ 4286.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of -1.6% during the forecast period.
The US & Canada market for Gastroesophageal Reflux Disease (GERD) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Gastroesophageal Reflux Disease (GERD) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Gastroesophageal Reflux Disease (GERD) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Gastroesophageal Reflux Disease (GERD) Therapeutics include AstraZeneca, Eisai, GSK, Takeda and Johnson & Johnson, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Gastroesophageal Reflux Disease (GERD) Therapeutics is widely used in various fields, such as Heartburn and Acid reflux disorders, etc. Heartburn provides greatest supports to the Gastroesophageal Reflux Disease (GERD) Therapeutics industry development. In 2023, global % revenue of Gastroesophageal Reflux Disease (GERD) Therapeutics went into Heartburn filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Gastroesophageal Reflux Disease (GERD) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Gastroesophageal Reflux Disease (GERD) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastroesophageal Reflux Disease (GERD) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastroesophageal Reflux Disease (GERD) Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gastroesophageal Reflux Disease (GERD) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Eisai, GSK, Takeda and Johnson & Johnson, etc.

Market Segmentation
By Company
    AstraZeneca
    Eisai
    GSK
    Takeda
    Johnson & Johnson

Segment by Type
    Antacids
    Pro-kinetic agents
    H2 Receptor Blockers
    Proton Pump Inhibitors (PPIs)

Segment by Application
    Heartburn
    Acid reflux disorders

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gastroesophageal Reflux Disease (GERD) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease (GERD) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastroesophageal Reflux Disease (GERD) Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Antacids
    Table 3. Key Players of Pro-kinetic agents
    Table 4. Key Players of H2 Receptor Blockers
    Table 5. Key Players of Proton Pump Inhibitors (PPIs)
    Table 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2025-2030)
    Table 12. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
    Table 13. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
    Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
    Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
    Table 16. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Players (2019-2024)
    Table 18. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2023)
    Table 19. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Gastroesophageal Reflux Disease (GERD) Therapeutics, Headquarters and Area Served
    Table 22. Global Key Players of Gastroesophageal Reflux Disease (GERD) Therapeutics, Product and Application
    Table 23. Global Key Players of Gastroesophageal Reflux Disease (GERD) Therapeutics, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Application (2019-2024)
    Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Share by Application (2025-2030)
    Table 33. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 65. AstraZeneca Company Details
    Table 66. AstraZeneca Business Overview
    Table 67. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 68. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 69. AstraZeneca Recent Developments
    Table 70. Eisai Company Details
    Table 71. Eisai Business Overview
    Table 72. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 73. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 74. Eisai Recent Developments
    Table 75. GSK Company Details
    Table 76. GSK Business Overview
    Table 77. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 78. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 79. GSK Recent Developments
    Table 80. Takeda Company Details
    Table 81. Takeda Business Overview
    Table 82. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 83. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 84. Takeda Recent Developments
    Table 85. Johnson & Johnson Company Details
    Table 86. Johnson & Johnson Business Overview
    Table 87. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product
    Table 88. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 89. Johnson & Johnson Recent Developments
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Antacids Features
    Figure 4. Pro-kinetic agents Features
    Figure 5. H2 Receptor Blockers Features
    Figure 6. Proton Pump Inhibitors (PPIs) Features
    Figure 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Heartburn Case Studies
    Figure 10. Acid reflux disorders Case Studies
    Figure 11. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
    Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2023
    Figure 18. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2019-2030)
    Figure 20. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2019-2030)
    Figure 21. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2019-2030)
    Figure 22. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2019-2030)
    Figure 26. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2019-2030)
    Figure 27. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2019-2030)
    Figure 28. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2019-2030)
    Figure 36. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2019-2030)
    Figure 37. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2019-2030)
    Figure 39. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2019-2030)
    Figure 41. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2019-2030)
    Figure 51. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024)
    Figure 58. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024)
    Figure 59. GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024)
    Figure 60. Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed